Venture capital firm Avalon secures $200M for ninth fund

01/10/2011 | Xconomy

Avalon Ventures is expected to announce today that it raised $200 million for its ninth venture fund. The San Diego-based venture capital firm plans to continue making investments in early-stage firms specializing in life sciences and digital media, said Avalon founder Kevin Kinsella. Biotech firm RQx Pharmaceuticals is one of six companies that already has received funding from Avalon Ventures IX fund.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care